Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
Tags Pharmaceuticals Novo Nordisk A/S Health care industry
From CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
Tags US: News LILLY DRN Business
From CNBC.com News
Cramer's Lightning Round: 'I'd be careful' with Novo Nordisk
Tags Investment Strategy U/S/ Markets Markets
From CNBC.com News
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown
Tags Teladoc Health Inc US: News Health & Science
From CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Tags Weight management Companies Health care costs
From CNBC.com News
CNBC Daily Open: With cooler-than-expected PCE, would the Fed’s dot plot have looked different?
Tags Asia Markets Inflation Daily Open
From CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
Tags Science LILLY DRN US: News
From CNBC.com News
Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results
Tags Breaking News: Markets Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Tags Roche Holding AG Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
Europe's economy faces a bumpy ride in 2025. Here are 5 things to watch
Tags Stock markets Markets Europe Markets
From CNBC.com News
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
Tags Social issues Health & Science Science
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags LILLY DRN Health & Science Social issues
From CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
Tags Companies Health care industry US: News
From CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
Tags Health care industry Prescription drugs Crime
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags Amgen Inc Social issues GE HealthCare Technologies Inc
From CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
Tags Business News Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Hiccups in ETFs tracking MicroStrategy occurring as bull market fuels trading boom in single-stock funds
Tags Investing Tesla Inc NVIDIA Corp
From CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Tags Health care industry Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags DICK'S Sporting Goods Inc Novo Nordisk A/S Business News
From CNBC.com News
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
Tags Breaking news Amgen Inc Companies
From CNBC.com News
Amgen stock falls as analysts mull over weight loss drug’s bone density data
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Tags Healthy Returns Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
Tags Health & Science Social issues Science
From CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
Tags Health care industry Companies Breaking news
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Tags Companies Weight management Alzheimer's disease
From CNBC.com News
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
Tickers HIMS LLY NEWS NVO
Tags General semaglutide Benzinga
From Benzinga
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
Tags Social issues Health & Science Science
From CNBC.com News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
Tags Biotechnology Companies Business
From CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
Tags Health care industry Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Cramer's Lightning Round: Uranium Energy is 'the real deal'
Tags Stock Picks Novo Nordisk A/S stocks
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.